The MAP-19 Study was initiated in 2020 and investigated the mental health sequelae tied to the COVID-19 pandemic and its mitigation protocols, in addition to factors predicting adherence to viral mitigation protocols and preventive health behaviours (e.g., vaccination uptake). Participants included over 10,000 adults from Norway, followed up with 10 repeated assessment waves over 3 years. A subsample of over 2,750 participants was recruited for the Daily Diary sub-study, where each participant completed daily assessments over 40 days (yielding more than 108,000 observations) to investigate the granular mechanisms and contextual stressors related to a diverse range of mental and physical health problems experienced during the pandemic. The MAP-19 study includes an extensive and comprehensive measurement of mental health outcomes, physical health outcomes, COVID-19 infection and related variables, contextual variables, sociodemographic circumstances, as well as risk factors and associated psychosocial mechanisms.
Study design
Cohort, Registry
Number of participants at first data collection
10,061 (participants)
Age at first data collection
18 - 87 years (participants: longitudinal self-report data)
18 - 86 years (participants: daily diary data)
18 - 90 years (participants: registry)
Participant year of birth
Varied (participants: longitudinal self-report data)
Varied (participants: daily-diary study data)
Varied (participants: registry)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2020
Primary Institutions
Modum Bad Psychiatric Hospital
University of Oslo (Universitetet i Oslo)
University of Oxford
Links
sv.uio.no/psi/english/research/projects/the-norwegian-covid-19-mental-health-and-adherence/
psy.ox.ac.uk/research/emotional-disorder-genesis-and-evolution
Profile paper DOI
Not available
Funders
No funding information available
Ongoing?
No
Data types collected
Engagement
Keywords
Consortia and dataset groups